Nureca Limited Stock Price Today (NSE: NURECA)
Fundamental Score
Nureca Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nureca Limited share price today is ₹338.30, up +5.00% on NSE/BSE as of 16 September 2026. Nureca Limited (NURECA) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹322.81 (Cr). The 52-week high for NURECA share price is ₹358.00 and the 52-week low is ₹204.00. At a P/E ratio of 78.67x, NURECA is currently trading above its industry average P/E of 36.70x. 0
Nureca Limited Share Price Chart — NSE/BSE Historical Performance
Nureca Limited share price chart: -4.83% return over the past month. 52-week high ₹358.00, 52-week low ₹204.00.
Nureca Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹322.20 | ₹338.30 | ₹318.00 | ₹338.30 | 12.35K (Cr) | |
| ₹330.00 | ₹345.00 | ₹322.10 | ₹322.20 | 5.71K (Cr) | |
| ₹343.55 | ₹346.95 | ₹330.00 | ₹332.75 | 5.81K (Cr) | |
| ₹335.00 | ₹350.70 | ₹335.00 | ₹343.55 | 21.93K (Cr) | |
| ₹316.55 | ₹334.00 | ₹316.55 | ₹334.00 | 12.84K (Cr) | |
| ₹320.00 | ₹324.90 | ₹311.00 | ₹318.10 | 3.40K (Cr) | |
| ₹322.70 | ₹325.00 | ₹313.10 | ₹319.20 | 2.87K (Cr) | |
| ₹331.90 | ₹331.90 | ₹320.10 | ₹322.70 | 5.56K (Cr) | |
| ₹333.00 | ₹345.55 | ₹321.25 | ₹332.60 | 4.47K (Cr) | |
| ₹338.05 | ₹338.05 | ₹330.30 | ₹336.75 | 1.66K (Cr) |
Nureca Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹332.45 | ₹350.70 | ₹311.00 | ₹338.30 | +1.76% | |
| ₹332.20 | ₹358.00 | ₹290.20 | ₹331.80 | -0.12% | |
| ₹239.81 | ₹347.45 | ₹224.02 | ₹343.60 | +43.28% | |
| ₹232.30 | ₹249.60 | ₹226.55 | ₹237.40 | +2.20% | |
| ₹265.45 | ₹300.00 | ₹258.95 | ₹281.45 | +6.03% | |
| ₹208.05 | ₹274.90 | ₹208.05 | ₹266.51 | +28.10% | |
| ₹289.20 | ₹295.15 | ₹204.00 | ₹206.75 | -28.51% | |
| ₹275.00 | ₹307.00 | ₹265.15 | ₹295.20 | +7.35% | |
| ₹316.00 | ₹334.50 | ₹270.00 | ₹277.85 | -12.07% | |
| ₹294.00 | ₹315.00 | ₹270.50 | ₹307.95 | +4.74% | |
| ₹260.00 | ₹293.00 | ₹247.00 | ₹289.60 | +11.38% | |
| ₹229.00 | ₹343.00 | ₹226.84 | ₹261.50 | +14.19% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nureca Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nureca Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NURECA across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Revenue Growth (18.04%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 15.32)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (64.97%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
11 factors identified
Below-Average Return on Equity (0.00%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.30%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.16%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 78.67x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-100.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Growth History (-7.19% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-49.15% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-46.15% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-25.50 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.52%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nureca Limited vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Nureca Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Nureca LimitedNureca Limited...Selected✓ NURECA • 543264 | 16.5/100 | ₹338.30₹338 | ₹322.81₹322.81 | 78.67Average 78.7 Average | 0.00%Poor 0.00% Poor | 3.30%Poor 3.30% Poor | 0.00Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
Poly Medicure LimitedPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1724.00₹1724 | ₹17474.36₹17474.36 | 55.45Average 55.5 Average | 10.97%Average 10.97% Average | 14.28%Average 14.28% Average | 0.11Excellent 0.1 Excellent | 18.85%Excellent 18.85% Excellent | 18.98%Excellent 18.98% Excellent | 0.20% |
Fischer Medical Ventures LimitedFischer Medical... FISCHER • 524743 | 21.9/100 | ₹34.60₹35 | ₹2264.62₹2264.62 | 14.42Average 14.4 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.19Excellent 0.2 Excellent | — — | — — | 0.01% |
Tarsons Products LimitedTarsons Product... TARSONS • 543399 | 17.1/100 | ₹321.35₹321 | ₹1709.74₹1709.74 | 153.76Average 153.8 Average | 0.00%Poor 0.00% Poor | 4.87%Poor 4.87% Poor | 0.60Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LimitedLaxmi Dental Li... LAXMIDENTL • 544339 | 69.6/100 | ₹201.14₹201 | ₹1105.47₹1105.47 | 35.54Average 35.5 Average | 12.83%Average 12.83% Average | 12.34%Average 12.34% Average | 0.00Excellent 0.0 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹369.90₹370 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹468.00₹468 | ₹610.20₹610.20 | 30.06Average 30.1 Average | 18.16%Good 18.16% Good | 24.15%Excellent 24.15% Excellent | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹387.00₹387 | ₹464.52₹464.52 | 20.38Average 20.4 Average | 18.60%Good 18.60% Good | 23.74%Excellent 23.74% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
20.7/100 | ₹151.80₹152 | ₹293.54₹293.54 | 30.79Average 30.8 Average | 10.45%Average 10.45% Average | 19.30%Good 19.30% Good | 0.65Good 0.7 Good | — — | — — | 0.45% | |
38.2/100 | ₹103.25₹103 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
32.1/100 | ₹150.00₹150 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Limited share price17474.36 Cr
- Fischer Medical Ventures Limited share price2264.62 Cr
- Tarsons Products Limited share price1709.74 Cr
- Laxmi Dental Limited share price1105.47 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
Nureca Limited PE Ratio History
Historical price-to-earnings ratio for NURECA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.85 | ₹307.95 | 362.3x |
| FY 2022 | ₹44.96 | ₹498.15 | 11.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Nureca Limited Dividend History
Annual cash dividends paid by NURECA — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2022 | ₹4.99 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Nureca Limited Quarterly Performance
Latest quarterly metrics for NURECA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
18.04%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-100.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-7.19%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-46.15%
Compounded annual net profit growth over 5 years
Nureca Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NURECA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nureca Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nureca Limited (NURECA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Nureca Limited
About NURECA (Nureca Limited)
Nureca Ltd is a dynamic Indian enterprise focused on empowering individuals to proactively manage their health and well-being from the comfort of their homes. They curate and distr...ibute a comprehensive range of medical devices and lifestyle products designed to address both acute and chronic conditions. The company's portfolio encompasses essential diagnostic tools, enabling users to monitor vital signs and track key health indicators. Beyond diagnostics, Nureca offers solutions for pain management, rehabilitation, and overall physical wellness. Their dedication to providing high-quality, user-friendly products reflects a commitment to making healthcare accessible and convenient for all. Nureca's offerings span a wide spectrum of needs, ranging from devices that assist in managing respiratory ailments to innovative gadgets that promote fitness and relaxation. For individuals grappling with chronic conditions, they provide essential tools like blood glucose monitors for diabetes management, and blood pressure monitors for hypertension control. Simultaneously, Nureca caters to the growing interest in preventive healthcare and wellness by offering products such as posture correctors and massagers that aid in musculoskeletal health. This holistic approach underscores their vision of creating a healthier and more informed society. The company strategically positions itself at the intersection of healthcare and technology, integrating connected features into select products to enhance user experience and data tracking. By seamlessly blending traditional medical devices with modern connectivity, Nureca strives to provide consumers with a comprehensive and integrated approach to healthcare management. Their dedication to product quality, coupled with their commitment to innovation and customer satisfaction, solidifies Nureca's position as a leader in the rapidly evolving home healthcare market in India.
Company Details
Key Leadership
NURECA Share Price: Frequently Asked Questions
What is the current share price of Nureca Limited?
Nureca Limited (NURECA) trades at ₹338.30 on NSE and BSE. Market cap ₹322.81 (Cr). Educational data only.
What is the P/E ratio of Nureca Limited?
Nureca Limited has a P/E of 78.67x vs industry average 36.70x.
What is the Bull Run score for Nureca Limited?
Nureca Limited has a Bull Run score of 16.5/100 based on 25+ financial parameters.
Does Nureca Limited pay dividends?
Nureca Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Nureca Limited?
Nureca Limited has ROE of 0.00%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nureca Limited?
Nureca Limited has debt-to-equity of 0.00.
Is Nureca Limited a good investment?
Bull Run gives Nureca Limited a score of 16.5/100. This is not investment advice — consult a SEBI-registered advisor.